The American College of Obstetricians and Gynecologists has released a practice bulletin to help providers use scientific evidence to guide women with coexisting medical conditions in making the most effective choices.
Family planning providers should develop ways to provide contraceptives to patients in one visit (known as Quick Start) for all methods, according to the Family Planning National Training Center’s Contraceptive Access Change Package. New research indicates that while most public-sector and private providers consider Quick Start for combined hormonal contraceptives and depot medroxyprogesterone acetate (DMPA) safe for use among adolescents, fewer private providers utilize the technique.
The American College of Obstetricians and Gynecologists has issued a new committee opinion designed to help clinicians aid patients in managing symptoms of dysmenorrhea effectively so that women may continue everyday activities with minimal disruption.
Highly publicized results from the Danish database demonstrate an increase in the risk of breast cancer associated with current use of hormonal contraception. Consistent with prior research, the risk is small, confined to current users, and disappears following discontinuation.
Large study includes all forms of current hormonal contraception
December 28, 2017
Results from a study of 1.8 million Danish women ages 15-49 indicate that the risk of breast cancer is increased among women who currently or recently used contemporary hormonal contraceptives compared to those women who have never used such methods. While the risk increased with longer use, the absolute increases in risk were small.